Menu
Enrolling by invitation NCT06629701

A Prospective Randomized Trial of External Vein Graft Support in Surgical Myocardial Revascularization

No phase Interventional Heart Attack, Revascularization

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: External support for vein grafts.
Who it may be relevant to
Registry conditions: Heart Attack, Revascularization. Basic parameters: 20 years — 90 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Czechia
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The aim of the thesis is to compare a group of patients using vein grafts with and without external support, specifically their patency. This is a prospective study with a follow-up plan of 150 patients, in whom the functionality of the grafts will be monitored at time intervals.

Detailed description

One of the most frequently used strategies to restore blood flow in affected coronary arteries in atherosclerotic disease is coronary bypass, or bridging of a narrowed or closed artery and revascularization of the ischemic area of the heart. For coronary artery bypass grafting (CABG), the great saphenous vein (VSM) remains the most commonly used graft, although the longevity of the vein graft is an important limiting factor in monitoring long-term results of CABG. Long-term follow-up found that 25% of vein grafts close within 1 year of surgery, and up to 75% of vein grafts close 10 years after surgery.

External support minimizes pathophysiological processes in the graft. For example, intimal hyperplasia, kinking, graft dilatation or graft suppression and generally improving the hemodynamic flow through the graft should also reduce the formation of thrombus. In this study we follow up the patency and function of vein grafts over a period of 4 years, and compare the resulting data with already available data from other researches.

Interventions

  • Device External support for vein grafts
    Group A will consist of a group of patients who will be sutured with external support for vein grafts.

Primary outcome measures

  • Closing of bypass in time [Time frame: 3 years after the operation]
Secondary outcome measures (2)
  • Chest pain [Time frame: 3 years after the operation]
  • Shortness of breath at rest [Time frame: 3 years after the operation]

Eligibility criteria

Inclusion criteria

  • elective cardiosurgical revascularization using VSM vein graft, i.e. patients with MVD findings.

Exclusion criteria

  • thromboembolic event in the past, long-term warfarinization, mechanical valves, infection during the procedure, urgent procedure, allergy to contrast material, pregnancy, elevated creatinine. A relative contraindication for exclusion from the study is: VSM varicosity, VSM damage during sampling.The age, gender or weight of the patient has no influence on the indication.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Device feasibility

Study locations

Czechia · 1 center
  • University Hospital Pilsen — Pilsen

Identifiers

NCT: NCT06629701 · Vest II

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗